Breaking News Instant updates and real-time market news.

NNOX

Nano-X Imaging

$26.67 /

-2.32 (-8.00%)

09:00
10/29/20
10/29
09:00
10/29/20
09:00

Nano-X Imaging signs with Ambra Health to enable image access, transfer

NANO-X IMAGING announced it has signed an agreement with Ambra Health to facilitate the transfer of medical images between U.S. hospitals and medical imaging providers. Per the terms of the agreement, Ambra will serve as the enterprise image exchange solution, integrated with planned U.S. Nanox.ARC system deployments via the Nanox.CLOUD infrastructure, subject to approval of the Nanox.ARC system by the FDA. The Ambra suite consolidates multiple imaging systems with one flexible, customizable, and low maintenance cloud storage platform that lets medical imaging be accessed securely, anytime, anywhere. Leading facilities use Ambra to connect directly to multiple modalities and imaging systems, creating a unified source of imaging data that is accessible to providers and patients. The unification of imaging data allows for significant daily workflow improvements, opportunities for new research and development, and enhanced communication with patients in image-enabled patient and second opinion portals. Ambra's network allows providers to seamlessly connect with innovative imaging partners like Nanox. Ambra has over eight billion images under its management and is used in over 50 countries.

  • 09

    Nov

  • 21

    Aug

NNOX Nano-X Imaging
$26.67 /

-2.32 (-8.00%)

09/15/20 Cantor Fitzgerald
Cantor reiterates $70 target on Nano-X after 'unfounded' short report
09/15/20 Cantor Fitzgerald
Nano-X Imaging concerns in short report unfounded, says Cantor Fitzgerald
09/15/20 Oppenheimer
Nano-X Imaging initiated with a Perform at Oppenheimer
09/15/20 Berenberg
Nano-X Imaging initiated with a Buy at Berenberg

TODAY'S FREE FLY STORIES

Earnings
HP Enterprise sees Q1 adjusted EPS 40c-44c, consensus 35c » 16:06
12/01/20
12/01
16:06
12/01/20
16:06
HPE

HP Enterprise

$11.27 /

+0.235 (+2.13%)

Fiscal 2021 first quarter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HPE HP Enterprise
$11.27 /

+0.235 (+2.13%)

HPE HP Enterprise
$11.27 /

+0.235 (+2.13%)

11/16/20
Fly Intel: Top five analyst upgrades
11/16/20 Raymond James
HP Enterprise upgraded to Outperform from Market Perform at Raymond James
11/16/20 Raymond James
HP Enterprise upgraded to Outperform from Market Perform at Raymond James
09/22/20 UBS
HP Enterprise assumed with a Neutral at UBS
HPE HP Enterprise
$11.27 /

+0.235 (+2.13%)

HPE HP Enterprise
$11.27 /

+0.235 (+2.13%)

HPE HP Enterprise
$11.27 /

+0.235 (+2.13%)

HPE HP Enterprise
$11.27 /

+0.235 (+2.13%)

Hot Stocks
Agree Realty raises dividend 6% to 62c » 16:06
12/01/20
12/01
16:06
12/01/20
16:06
ADC

Agree Realty

$66.29 /

+0.39 (+0.59%)

The Board of Directors…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADC Agree Realty
$66.29 /

+0.39 (+0.59%)

ADC Agree Realty
$66.29 /

+0.39 (+0.59%)

10/12/20 BTIG
Agree Realty initiated with a Buy at BTIG
09/29/20 Mizuho
Agree Realty initiated with a Buy at Mizuho
07/02/20 Citi
Agree Realty price target raised to $76 from $70 at Citi
06/10/20 Wells Fargo
Agree Realty price target raised to $75 from $67 at Wells Fargo
ADC Agree Realty
$66.29 /

+0.39 (+0.59%)

  • 31
    Mar
Hot Stocks
HP Enterprise to relocate headquarters to Houston, Texas » 16:06
12/01/20
12/01
16:06
12/01/20
16:06
HPE

HP Enterprise

$11.29 /

+0.26 (+2.36%)

HPE has made the decision…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

11/16/20
Fly Intel: Top five analyst upgrades
11/16/20 Raymond James
HP Enterprise upgraded to Outperform from Market Perform at Raymond James
11/16/20 Raymond James
HP Enterprise upgraded to Outperform from Market Perform at Raymond James
09/22/20 UBS
HP Enterprise assumed with a Neutral at UBS
HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

Syndicate
Reata Pharmaceuticals announces offering of 2M shares of Class A common stock » 16:06
12/01/20
12/01
16:06
12/01/20
16:06
RETA

Reata Pharmaceuticals

$151.36 /

-1.21 (-0.79%)

Reata Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RETA Reata Pharmaceuticals
$151.36 /

-1.21 (-0.79%)

RETA Reata Pharmaceuticals
$151.36 /

-1.21 (-0.79%)

11/25/20 Citi
Reata Pharmaceuticals price target lowered to $234 from $260 at Citi
11/10/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $220 from $169 at Cantor Fitzgerald
11/10/20 Citi
Reata Pharmaceuticals price target raised to $260 from $244 at Citi
08/11/20 Cantor Fitzgerald
Reata Pharmaceuticals price target lowered to $169 from $275 at Cantor Fitzgerald
RETA Reata Pharmaceuticals
$151.36 /

-1.21 (-0.79%)

RETA Reata Pharmaceuticals
$151.36 /

-1.21 (-0.79%)

Earnings
HP Enterprise reports Q4 adjusted EPS 37c, consensus 34c » 16:05
12/01/20
12/01
16:05
12/01/20
16:05
HPE

HP Enterprise

$11.29 /

+0.26 (+2.36%)

Reports Q4 revenue $7.2B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

11/16/20
Fly Intel: Top five analyst upgrades
11/16/20 Raymond James
HP Enterprise upgraded to Outperform from Market Perform at Raymond James
11/16/20 Raymond James
HP Enterprise upgraded to Outperform from Market Perform at Raymond James
09/22/20 UBS
HP Enterprise assumed with a Neutral at UBS
HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

Hot Stocks
Tredegar declares special dividend of $5.97 per share » 16:05
12/01/20
12/01
16:05
12/01/20
16:05
TG

Tredegar

$16.60 /

+0.85 (+5.40%)

Tredegar announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TG Tredegar
$16.60 /

+0.85 (+5.40%)

Conference/Events
AdaptHealth participates in a conference call with Jefferies » 16:05
12/01/20
12/01
16:05
12/01/20
16:05
AHCO

AdaptHealth

$35.45 /

+5.61 (+18.80%)

Healthcare Equity…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AHCO AdaptHealth
$35.45 /

+5.61 (+18.80%)

AHCO AdaptHealth
$35.45 /

+5.61 (+18.80%)

11/17/20 Deutsche Bank
AdaptHealth price target raised to $36 from $26 at Deutsche Bank
11/16/20 Baird
AdaptHealth initiated with an Outperform at Baird
11/05/20 SVB Leerink
AdaptHealth price target raised to $32.50 from $23.50 at SVB Leerink
08/11/20 RBC Capital
AdaptHealth price target raised to $33 from $24 at RBC Capital
AHCO AdaptHealth
$35.45 /

+5.61 (+18.80%)

  • 03
    Sep
  • 01
    Jul
AHCO AdaptHealth
$35.45 /

+5.61 (+18.80%)

Hot Stocks
NetApp CEO says company 'uniquely positioned' to help w/ digital transformations » 16:04
12/01/20
12/01
16:04
12/01/20
16:04
NTAP

NetApp

$54.24 /

+0.97 (+1.82%)

CEO George Kurian says:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTAP NetApp
$54.24 /

+0.97 (+1.82%)

NTAP NetApp
$54.24 /

+0.97 (+1.82%)

11/30/20 Deutsche Bank
NetApp price target raised to $50 from $45 at Deutsche Bank
11/12/20 Wedbush
NetApp initiated with a Neutral at Wedbush
11/12/20 Wedbush
NetApp initiated with a Neutral at Wedbush
10/29/20 OTR Global
NetApp upgraded to Mixed from Negative at OTR Global
NTAP NetApp
$54.24 /

+0.97 (+1.82%)

NTAP NetApp
$54.24 /

+0.97 (+1.82%)

NTAP NetApp
$54.24 /

+0.97 (+1.82%)

NTAP NetApp
$54.24 /

+0.97 (+1.82%)

Hot Stocks
Oyster Point Pharma submits OC-01 nasal spray trial protocol to FDA » 16:03
12/01/20
12/01
16:03
12/01/20
16:03
OYST

Oyster Point Pharma

$21.45 /

+0.08 (+0.37%)

Oyster Point Pharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OYST Oyster Point Pharma
$21.45 /

+0.08 (+0.37%)

OYST Oyster Point Pharma
$21.45 /

+0.08 (+0.37%)

08/05/20 Piper Sandler
Oyster Point Pharma remains 'fundamentally undervalued,' says Piper Sandler
05/13/20 H.C. Wainwright
H.C. Wainwright reiterates Buy on Kala after 'underwhelming' competitor data
05/11/20 Piper Sandler
Piper says Oyster Point 'highly likely' to get dry eye approval, superior label
03/30/20 Piper Sandler
Oyster Point ONSET-2 trial barely impacted by COVID-19, says Piper Sandler
OYST Oyster Point Pharma
$21.45 /

+0.08 (+0.37%)

  • 15
    May
Earnings
NetApp sees Q3 EPS 94c-$1.02, consensus 89c  16:03
12/01/20
12/01
16:03
12/01/20
16:03
NTAP

NetApp

$54.20 /

+0.93 (+1.75%)

 
ShowHide Related Items >><<
NTAP NetApp
$54.20 /

+0.93 (+1.75%)

NTAP NetApp
$54.20 /

+0.93 (+1.75%)

11/30/20 Deutsche Bank
NetApp price target raised to $50 from $45 at Deutsche Bank
11/12/20 Wedbush
NetApp initiated with a Neutral at Wedbush
11/12/20 Wedbush
NetApp initiated with a Neutral at Wedbush
10/29/20 OTR Global
NetApp upgraded to Mixed from Negative at OTR Global
NTAP NetApp
$54.20 /

+0.93 (+1.75%)

NTAP NetApp
$54.20 /

+0.93 (+1.75%)

NTAP NetApp
$54.20 /

+0.93 (+1.75%)

NTAP NetApp
$54.20 /

+0.93 (+1.75%)

Syndicate
Twist Bioscience files to sell $325M in common stock » 16:02
12/01/20
12/01
16:02
12/01/20
16:02
TWST

Twist Bioscience

$118.29 /

+6.06 (+5.40%)

Twist Bioscience…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWST Twist Bioscience
$118.29 /

+6.06 (+5.40%)

TWST Twist Bioscience
$118.29 /

+6.06 (+5.40%)

11/24/20 SVB Leerink
Twist Bioscience price target raised to $100 from $90 at SVB Leerink
11/24/20 Baird
Twist Bioscience price target raised to $125 from $70 at Baird
10/20/20 SVB Leerink
Twist Bioscience initiated with a Market Perform at SVB Leerink
02/06/20 Cowen
Developments in Agilent-Twist dispute could mean settlement imminent, says Cowen
TWST Twist Bioscience
$118.29 /

+6.06 (+5.40%)

  • 04
    Jun
  • 20
    Feb
TWST Twist Bioscience
$118.29 /

+6.06 (+5.40%)

Earnings
Vapotherm raises FY20 revenue view to $114.8M-$117.8M, consensus $103.91M » 16:02
12/01/20
12/01
16:02
12/01/20
16:02
VAPO

Vapotherm

$25.01 /

-0.12 (-0.48%)

Previous view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

11/05/20 Canaccord
Vapotherm price target lowered to $40 from $54 at Canaccord
07/13/20 BTIG
Vapotherm price target raised to $53 from $32 at BTIG
06/05/20 Canaccord
Vapotherm price target raised to $34 from $30 at Canaccord
05/06/20 Canaccord
Vapotherm price target raised to $30 from $20 at Canaccord
VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

  • 07
    May
VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

Earnings
NetApp reports Q2 EPS $1.05, consensus 73c » 16:02
12/01/20
12/01
16:02
12/01/20
16:02
NTAP

NetApp

$54.15 /

+0.88 (+1.65%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTAP NetApp
$54.15 /

+0.88 (+1.65%)

NTAP NetApp
$54.15 /

+0.88 (+1.65%)

11/30/20 Deutsche Bank
NetApp price target raised to $50 from $45 at Deutsche Bank
11/12/20 Wedbush
NetApp initiated with a Neutral at Wedbush
11/12/20 Wedbush
NetApp initiated with a Neutral at Wedbush
10/29/20 OTR Global
NetApp upgraded to Mixed from Negative at OTR Global
NTAP NetApp
$54.15 /

+0.88 (+1.65%)

NTAP NetApp
$54.15 /

+0.88 (+1.65%)

NTAP NetApp
$54.15 /

+0.88 (+1.65%)

NTAP NetApp
$54.15 /

+0.88 (+1.65%)

Earnings
Vapotherm raises Q4 revenue view to $30M-$33M from $18M-$20M » 16:02
12/01/20
12/01
16:02
12/01/20
16:02
VAPO

Vapotherm

$25.01 /

-0.12 (-0.48%)

Consensus $19.04M.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

11/05/20 Canaccord
Vapotherm price target lowered to $40 from $54 at Canaccord
07/13/20 BTIG
Vapotherm price target raised to $53 from $32 at BTIG
06/05/20 Canaccord
Vapotherm price target raised to $34 from $30 at Canaccord
05/06/20 Canaccord
Vapotherm price target raised to $30 from $20 at Canaccord
VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

  • 07
    May
VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

Conference/Events
Credit Suisse healthcare analysts to hold analyst/industry conference call » 15:59
12/01/20
12/01
15:59
12/01/20
15:59

Analysts, along with Dr.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Periodicals
CoreLogic interest seen being 'strong,' CTFN reports » 15:56
12/01/20
12/01
15:56
12/01/20
15:56
CLGX

CoreLogic

$78.02 /

+0.515 (+0.66%)

CTFN's Diane Alter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLGX CoreLogic
$78.02 /

+0.515 (+0.66%)

CLGX CoreLogic
$78.02 /

+0.515 (+0.66%)

07:34 Today Truist
CoreLogic downgraded to Hold from Buy at Truist
06:45 Today Truist
CoreLogic downgraded to Hold from Buy at Truist
10/28/20 Truist
CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist
09/22/20 Truist
CoreLogic increasingly likely to see other financial suitors, says Truist
CLGX CoreLogic
$78.02 /

+0.515 (+0.66%)

CLGX CoreLogic
$78.02 /

+0.515 (+0.66%)

CLGX CoreLogic
$78.02 /

+0.515 (+0.66%)

Hot Stocks
Tredegar trading halted, news pending  15:45
12/01/20
12/01
15:45
12/01/20
15:45
TG

Tredegar

$16.68 /

+0.925 (+5.87%)

 
ShowHide Related Items >><<
TG Tredegar
$16.68 /

+0.925 (+5.87%)

Options
Fitbit call volume above normal and directionally bullish » 15:45
12/01/20
12/01
15:45
12/01/20
15:45
FIT

Fitbit

$7.22 /

+0.04 (+0.56%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FIT Fitbit
$7.22 /

+0.04 (+0.56%)

FIT Fitbit
$7.22 /

+0.04 (+0.56%)

06/19/20 Deutsche Bank
Fitbit acquisition completing remains base case at Deutsche Bank
FIT Fitbit
$7.22 /

+0.04 (+0.56%)

FIT Fitbit
$7.22 /

+0.04 (+0.56%)

FIT Fitbit
$7.22 /

+0.04 (+0.56%)

FIT Fitbit
$7.22 /

+0.04 (+0.56%)

Periodicals
CTFN publishes report on CoreLogic auction plans » 15:42
12/01/20
12/01
15:42
12/01/20
15:42
CLGX

CoreLogic

$77.90 /

+0.3951 (+0.51%)

, CNNE

Cannae Holdings

$40.52 /

+1.16 (+2.95%)

CTFN's Diane Alter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLGX CoreLogic
$77.90 /

+0.3951 (+0.51%)

CNNE Cannae Holdings
$40.52 /

+1.16 (+2.95%)

CLGX CoreLogic
$77.90 /

+0.3951 (+0.51%)

07:34 Today Truist
CoreLogic downgraded to Hold from Buy at Truist
06:45 Today Truist
CoreLogic downgraded to Hold from Buy at Truist
10/28/20 Truist
CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist
09/22/20 Truist
CoreLogic increasingly likely to see other financial suitors, says Truist
CNNE Cannae Holdings
$40.52 /

+1.16 (+2.95%)

11/19/20 Oppenheimer
Cannae Holdings initiated with an Outperform at Oppenheimer
09/22/20 Truist
CoreLogic increasingly likely to see other financial suitors, says Truist
06/26/20 SunTrust
CoreLogic upgraded to Buy from Hold at SunTrust
05/14/20 Stephens
Cannae Holdings price target raised to $43 from $40 at Stephens
CLGX CoreLogic
$77.90 /

+0.3951 (+0.51%)

  • 11
    Jun
  • 04
    Dec
CLGX CoreLogic
$77.90 /

+0.3951 (+0.51%)

CNNE Cannae Holdings
$40.52 /

+1.16 (+2.95%)

CLGX CoreLogic
$77.90 /

+0.3951 (+0.51%)

CNNE Cannae Holdings
$40.52 /

+1.16 (+2.95%)

Options
Box options imply 14.0% move in share price post-earnings » 15:34
12/01/20
12/01
15:34
12/01/20
15:34
BOX

Box

$18.54 /

-0.14 (-0.75%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BOX Box
$18.54 /

-0.14 (-0.75%)

BOX Box
$18.54 /

-0.14 (-0.75%)

08/27/20 Craig-Hallum
Box price target raised to $30 from $24 at Craig-Hallum
08/27/20 Morgan Stanley
Box has large, attractive market opportunity, says Morgan Stanley
05/28/20 Raymond James
Box price target raised to $24 from $18 at Raymond James
05/28/20 Craig-Hallum
Box upgraded to Buy at Craig-Hallum on improved execution, net expansion
BOX Box
$18.54 /

-0.14 (-0.75%)

BOX Box
$18.54 /

-0.14 (-0.75%)

BOX Box
$18.54 /

-0.14 (-0.75%)

Hot Stocks
180 Life Sciences CEO says 'takes time to get word out' after coming public » 15:24
12/01/20
12/01
15:24
12/01/20
15:24
ATNF

180 Life Sciences

$2.68 /

-0.05 (-1.83%)

180 Life Sciences (ATNF)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATNF 180 Life Sciences
$2.68 /

-0.05 (-1.83%)

ATNF 180 Life Sciences
$2.68 /

-0.05 (-1.83%)

Conference/Events
Morgan Stanley large cap banks analyst to hold analyst/industry conference call » 15:23
12/01/20
12/01
15:23
12/01/20
15:23

US Large Cap Banks &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Options
Trip.com options imply 10.1% move in share price post-earnings » 15:19
12/01/20
12/01
15:19
12/01/20
15:19
TCOM

Trip.com Group

$34.24 /

+0.64 (+1.90%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCOM Trip.com Group
$34.24 /

+0.64 (+1.90%)

11/10/20 Credit Suisse
Trip.com Group upgraded to Outperform from Neutral at Credit Suisse
09/28/20 Barclays
Trip.com Group price target raised to $36 from $31 at Barclays
09/25/20 Mizuho
Trip.com Group price target raised to $33 from $29 at Mizuho
09/15/20
Fly Intel: Top analyst downgrades
TCOM Trip.com Group
$34.24 /

+0.64 (+1.90%)

TCOM Trip.com Group
$34.24 /

+0.64 (+1.90%)

TCOM Trip.com Group
$34.24 /

+0.64 (+1.90%)

Hot Stocks
Blueprint Medicines announces FDA approval of Gavreto » 15:17
12/01/20
12/01
15:17
12/01/20
15:17
BPMC

Blueprint Medicines

$106.16 /

-1.92 (-1.78%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

Blueprint Medicines…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BPMC Blueprint Medicines
$106.16 /

-1.92 (-1.78%)

RHHBY Roche
$0.00 /

+ (+0.00%)

BPMC Blueprint Medicines
$106.16 /

-1.92 (-1.78%)

11/02/20 Jefferies
Jefferies cuts Blueprint to Hold with current products' potential priced in
11/02/20 H.C. Wainwright
Blueprint Medicines price target raised to $135 from $110 at H.C. Wainwright
11/02/20 Jefferies
Blueprint Medicines downgraded to Hold from Buy at Jefferies
10/30/20
Fly Intel: Top five analyst downgrades
RHHBY Roche
$0.00 /

+ (+0.00%)

11/27/20 UBS
Roche price target lowered to CHF 365 from CHF 370 at UBS
11/11/20 Truist
Opthea initiated with a Buy at Truist
10/16/20 UBS
Roche price target lowered to CHF 370 from CHF 390 at UBS
10/06/20 Goldman Sachs
Goldman reiterates $34 target on Kiniksa after 'impressive' data
BPMC Blueprint Medicines
$106.16 /

-1.92 (-1.78%)

RHHBY Roche
$0.00 /

+ (+0.00%)

  • 23
    Jan
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Hot Stocks
Roche's Genentech announces FDA approval of Gavreto » 15:17
12/01/20
12/01
15:17
12/01/20
15:17
RHHBY

Roche

$0.00 /

+ (+0.00%)

Genentech, a member of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

11/27/20 UBS
Roche price target lowered to CHF 365 from CHF 370 at UBS
11/11/20 Truist
Opthea initiated with a Buy at Truist
10/16/20 UBS
Roche price target lowered to CHF 370 from CHF 390 at UBS
10/06/20 Goldman Sachs
Goldman reiterates $34 target on Kiniksa after 'impressive' data
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.